Olivier Bouché - Researcher Profile

Publications

4 shown

Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients

Michel Ducreux , Emmanuel Mitry , Mahmoud Ould-Kaci +10 more

2004 Annals of Oncology 114 citations

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy , Françoise Desseigne , Marc Ychou +17 more

International audience

2011 New England Journal of Medicine 7440 citations

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

Bruno Chauffert , F. Mornex , F. Bonnetain +12 more

The role of chemoradiation with systemic chemotherapy compared with chemotherapy alone in locally advanced pancreatic cancer (LAPC) is uncertain. One hundred and nineteen patien...

2008 Annals of Oncology 681 citations

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Axel Grothey , Eric Van Cutsem , Alberto Sobrero +17 more

No treatment options are available for patients with metastatic colorectal cancer that progresses after all approved standard therapies, but many patients maintain a good perfor...

2012 The Lancet 2789 citations

Frequent Co-Authors

Michel Ducreux

Institut Gustave Roussy

Emmanuel Mitry

Hôpital Ambroise-Paré

Mahmoud Ould-Kaci

Researcher Info

h-index: 4
Publications: 4
Citations: 11,024
Institution: Centre Hospitalier Universitaire de Reims

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-8284-3743

Impact Metrics

h-index 4

h-index: Number of publications with at least h citations each.